National Institutes of Health (NIH)

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

Study Examined Tecovirimat in Countries Affected by Global Clade II Mpox Outbreak.

Findings could pave the way for more personalized treatments for cardiovascular disease.

An observational study of more than 6,500 adults is one of the most detailed in the U.S.

New NIH-funded data show lower use of most substances continues following the COVID-19 pandemic.